Share Twitter LinkedIn Facebook Email Michael C. Soulen, MD of the University of Pennsylvania discusses primary resection of tumor in the gut and how there is evidence that there is no survival difference between resected and non-resected from ASCO GI 2018.
ASH 2025 MDS/ALL Highlights: Verona Trial Lessons & CLEVER Pathway | Dr. Jeyakumar Acute Lymphoblastic Leukemia 5 Mins Read
Advancing Acute Lymphoblastic Leukemia Treatment with CAR-T Cells: Insights from Dr. Anjali Advani Acute Lymphoblastic Leukemia 3 Mins Read